Hogan Lovells strengthens Corporate & Finance practice in Frankfurt with leading team hire

1 December 2021 – Global law firm Hogan Lovells has announced today that it is strengthening its Corporate practice in Frankfurt with the hire of two leading M&A specialists, Dr Christoph Naumann (joins 1 December 2021) and Dr Torsten Rosenboom (joins 1 January 2022) from Watson Farley & Williams. They will also be bringing with them a team of four associates and business lawyers.

Rosenboom is currently Office Managing Partner of Watson Farley & Williams  in Frankfurt and has played a key role in shaping the office in recent years. The corporate and M&A specialist is highly regarded in the market and focuses on advising on M&A transactions, joint ventures, restructurings and general corporate matters, particularly in the energy and infrastructure sector. Together with Dr Christoph Naumann he has established the M&A practice at Watson Farley & Williams. 

Naumann specialises in M&A, with a focus on private equity and venture capital. He has particular expertise in the technology and life sciences space.

James Doyle, global head of the Corporate & Finance practice at Hogan Lovells said: "We welcome Torsten, Christoph and the wider team to Hogan Lovells. Our German Corporate & Finance practice is one of the key engines of the firm. Their appointment adds to the depth and experience of our Germany M&A team who are already delivering high-end domestic and cross-border transactions for a broad range of clients. In line with our vision, we will continue to invest in key strategic markets and build on the progress we have made."

Dr Nikolas Zirngibl, head of the German Corporate & Finance practice group added: "Rosenboom and Naumann are an excellent fit with the culture of our firm, both professionally and personally. We are delighted to have them join; their appointments are an integral part of our growth strategy for the German Corporate & Finance practice."

"We are very excited to join Hogan Lovells. The firm has a collaborative culture and a strong global platform to help us grow our practices," said Dr Torsten Rosenboom and Dr Christoph Naumann. 


Back To Listing